BIODELIVERY SCIENCES INTL IN's ticker is BDSI and the CUSIP is 09060J106. A total of 104 filers reported holding BIODELIVERY SCIENCES INTL IN in Q1 2019. The put-call ratio across all filers is 0.46 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $524,000 | +146.0% | 168,999 | +186.1% | 0.00% | – |
| Q3 2021 | $213,000 | -10.9% | 59,075 | -11.4% | 0.00% | – |
| Q2 2021 | $239,000 | +121.3% | 66,700 | +140.8% | 0.00% | – |
| Q1 2021 | $108,000 | -77.3% | 27,700 | -75.5% | 0.00% | – |
| Q4 2020 | $476,000 | -52.8% | 113,165 | -58.2% | 0.00% | – |
| Q3 2020 | $1,009,000 | -10.5% | 270,460 | +4.7% | 0.00% | – |
| Q2 2020 | $1,127,000 | +24.1% | 258,428 | +7.9% | 0.00% | – |
| Q1 2020 | $908,000 | -84.7% | 239,464 | -74.5% | 0.00% | -100.0% |
| Q4 2019 | $5,932,000 | +720.5% | 938,709 | +446.4% | 0.00% | – |
| Q3 2019 | $723,000 | -47.0% | 171,798 | -41.4% | 0.00% | -100.0% |
| Q2 2019 | $1,363,000 | +52.0% | 293,112 | +73.2% | 0.00% | – |
| Q1 2019 | $897,000 | +617.6% | 169,260 | +399.0% | 0.00% | – |
| Q4 2018 | $125,000 | -58.7% | 33,923 | -68.7% | 0.00% | – |
| Q3 2018 | $303,000 | +9.8% | 108,439 | +16.1% | 0.00% | – |
| Q2 2018 | $276,000 | +688.6% | 93,384 | +492.4% | 0.00% | – |
| Q1 2018 | $35,000 | -88.1% | 15,764 | -84.2% | 0.00% | – |
| Q4 2017 | $293,000 | +16.3% | 99,472 | +16.5% | 0.00% | – |
| Q3 2017 | $252,000 | +189.7% | 85,364 | +175.2% | 0.00% | – |
| Q2 2017 | $87,000 | +148.6% | 31,015 | +69.5% | 0.00% | – |
| Q1 2017 | $35,000 | -81.2% | 18,300 | -82.8% | 0.00% | – |
| Q4 2016 | $186,000 | +42.0% | 106,285 | +119.5% | 0.00% | – |
| Q3 2016 | $131,000 | +54.1% | 48,423 | +34.0% | 0.00% | – |
| Q2 2016 | $85,000 | -72.4% | 36,133 | -62.1% | 0.00% | – |
| Q1 2016 | $308,000 | -91.7% | 95,361 | -87.6% | 0.00% | -100.0% |
| Q4 2015 | $3,689,000 | +738.4% | 770,196 | +873.3% | 0.00% | – |
| Q3 2015 | $440,000 | +233.3% | 79,136 | +377.9% | 0.00% | – |
| Q2 2015 | $132,000 | -96.9% | 16,559 | -95.9% | 0.00% | -100.0% |
| Q1 2015 | $4,200,000 | -26.5% | 400,006 | -15.8% | 0.00% | -33.3% |
| Q4 2014 | $5,712,000 | +331.1% | 475,193 | +512.8% | 0.01% | +500.0% |
| Q3 2014 | $1,325,000 | +17.9% | 77,547 | -16.6% | 0.00% | 0.0% |
| Q2 2014 | $1,124,000 | +1162.9% | 93,020 | +777.5% | 0.00% | – |
| Q1 2014 | $89,000 | – | 10,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthInvest Partners AB | 1,575,000 | $6,615,000 | 4.38% |
| 1492 Capital Management LLC | 790,863 | $3,322,000 | 1.91% |
| Rubric Capital Management LP | 3,516,124 | $14,768,000 | 1.08% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 9,530,000 | $40,026,000 | 0.79% |
| Zebra Capital Management LLC | 144,241 | $606,000 | 0.77% |
| KNOTT DAVID M | 370,230 | $1,555,000 | 0.70% |
| Nantahala Capital Management | 5,123,671 | $21,519,000 | 0.67% |
| SYSTEMATIC FINANCIAL MANAGEMENT LP | 3,593,893 | $15,094,000 | 0.66% |
| EMC Capital Management | 98,933 | $416,000 | 0.32% |
| ALGERT GLOBAL LLC | 175,170 | $736,000 | 0.21% |